Article Text

PDF
Interferon-α and pericardial injury: a case report and literature review
  1. Fayaz A Hakim1,
  2. Sujata Singh3,
  3. Anil Pandit1,
  4. Jorge R Alegria1,
  5. John Camoriano2,
  6. Melissa L Stanton4,
  7. Farouk Mookadam1
  1. 1Department of Cardiovascular Diseases, Scottsdale, Arizona, USA
  2. 2Hematology-Oncology, Scottsdale, Arizona, USA
  3. 3Internal Medicine, Scottsdale, Arizona, USA
  4. 4Laboratory Medicine and pathology, Mayo Clinic, Scottsdale, Arizona, USA
  1. Correspondence to Dr Farouk Mookadam, Mayo Clinic College of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85255, USA; mookadam.farouk{at}mayo.edu

Abstract

Interferon- α (IFN-α) alone or in combination with other chemotherapeutic agents has been used in the management of many malignant and non-malignant conditions. Pericarditis with or without pericardial effusion has been reported with IFN-α therapy, and available literature is limited to case reports. Pericardial constriction after interferon use has not been described in the published literature to date. We performed a systematic review of literature to address the demographic features, clinical presentation, diagnosis, treatment and outcome of interferon-related pericardial injury.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.